🔎 Trials Near Me

Dachaigh › Purpura Thrombocytopenic Idiopathic › New York

Sgrùdaidhean clionaigeach Purpura Thrombocytopenic Idiopathic ann an New York

Tha 7 sgrùdaidhean airson Purpura Thrombocytopenic Idiopathic a’ lorg phàirtichean aig làraichean ann an New York.

Bailtean ann an New York

Teacsa sgrùdaidh oifigeil (Beurla)

A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)

  • Montefiore Medical Center, The Bronx
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT07421167

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • Memorial Sloan Kettering Cancer Center, New York
  • Montefiore Medical Center, The Bronx
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Sult 2026 · NCT06722235

Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders

  • Montefiore Medical Center, The Bronx
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT07104565

A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)

  • NY Cancer and Blood Specialists, Shirley
A’ fastadhÌre 3
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT07059000

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • Memorial Sloan Kettering Cancer Center, New York
  • Montefiore Medical Center, The Bronx
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT06948318

Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment

  • New York Oncology Hematology-Investigational Site Number: 8400010, Albany
  • Montefiore Medical Center-Investigational Site Number: 8400012, The Bronx
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Ògmh 2026 · NCT07007962

Dose Dense Rituximab for High Risk Newly Diagnosed Acute Immune Thrombocytopenic Purpura

  • New York Medical College, Vahalla
A’ fastadhÌre 1
Aoisean 1 gu 21 · Gach gnè · Air ùrachadh 15 Gibl 2026 · NCT04323748

Bho ClinicalTrials.gov, dàta air a thogail 7 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.